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discriminating thecoma and fibrothecoma from
other adnexal solid masses
He Zhang1*, Guo-Fu Zhang1*, Tian-Ping Wang1 and Hao Zhang2Abstract
Background: To investigate the value of diffusion-weighted imaging (DWI) at 3.0 T (3T), and especially the
apparent diffusion coefficient (ADC), in discriminating ovarian thecoma from other adnexal solid masses.
Methods: Eighteen thecomas or fibrothecomas, 14 ligamentous leiomyomas, and 24 other ovarian solid tumors
underwent prospective DWI magnetic resonance imaging (MRI) in addition to routine MRI on a 3T MRI machine.
The baseline characteristics, components, and conventional MRI and DWI-MRI signals for the thecomas were
recorded. The ADC values (ADCs) were measured for each group and compared.
Results: The thecomas often appeared as homogeneous isointensity (17/18) on T1-weighted images (T1WI; 11/18)
or T2WI (11/18) on DWI-MRI, with minor (9/18) or mild (6/18) enhancement. The mean ADC value for thecoma
(1.20 ± 0.45 × 10−3 mm2/s) was almost equal to that of the other solid ovarian masses (1.26 ± 0.51 × 10−3 mm2/s),
but lower than that for leiomyoma (1.48 ± 0.42 × 10−3 mm2/s), although not significantly so. There was a significant
difference (p = 0.043) in the ADCs of the benign ovarian solid masses (1.16 ± 0.47 × 10−3 mm2/s) and leiomyomas
(1.48 ± 0.42 × 10−3 mm2/s).
Conclusions: There is no significant difference in ADC between thecoma and other adnexal solid masses, but the
ADCs of thecomas are lower than those of leiomyomas.
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Thecomas are rare, solid sex-cord stromal ovarian tumors,
and account for approximately 0.5%–1% of primary ovar-
ian lesions [1]. Although thecomas are often mixed with
fiber components (then called “fibrothecomas”), thecomas
and fibrothecomas are now considered to originate from
the ovarian medulla, with a different etiology from fibro-
mas, which originate from the cortex [2]. Because their
prevalence is so low, the imaging features of thecomas are
still not fully known [3,4]. Thecoma and fibrothecoma are
the most common solid primary ovarian tumors and
are frequently misdiagnosed as uterine fibroids [5].
Therefore, a better understanding of the imaging fea-
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reproduction in any medium, provided the orradiologists to ensure a correct preoperative diagnosis
of this disease. Magnetic resonance imaging (MRI) is a
second-line imaging modality with superb soft-tissue
resolution that is widely used in the clinical context to
examine any adnexal masses that are indeterminate on
either palpation or ultrasonography(US), with promis-
ing results [6-9]. In recent studies, perfusion-MRI and
diffusion-weighted imaging (DWI)-MRI have been used to
distinguish malignant ovarian tumors from benign condi-
tions [10,11]. However, to the best of our knowledge, 3.0
Tesla (3T) DWI-MRI evaluation of thecomas has not yet
been reported. Therefore, by evaluating thecomas on a 3T
MRI unit in this study, we aimed to: (1) describe the DWI
characteristics of thecomas and record the apparent diffu-
sion coefficient (ADC) for each lesion; (2) compare these
features with those of adnexal leiomyomas and other pri-
mary and secondary solid ovarian tumors to determineLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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thecomas from other solid adnexal masses.
Methods
Study subjects
Between January 2010 and August 2012, 347 consecutive
patients with clinically suspected adnexal disease under-
went 3T MRI examinations before pelvic or laparoscopic
surgery at our institution. The time interval between the
MRI evaluation and surgery was less than one month
(2–27 days; mean, 5 ± 12 days). Of these patients, 18
with histologically proven thecoma or fibrothecoma
(42–81 years of age; average age, 59.9 ± 10.8 years) [2]
were included in this study when we retrospectively re-
trieved the database on the Picture Archiving and Com-
munication System (PACS). Other solid or predominantly
solid adnexal masses, including histologically proven liga-
mentous leiomyomas (n = 14), primary ovarian masses
(n = 20), and recurrent ovarian masses (n = 4), were in-
cluded as the comparative group. Details of the samples
studied are summarized in Table 1. Our institutional re-
view board approved the study, and the requirement for
the informed consent of all participants was waived. In
this article, institutional review board was review board
of Shanghai First People’s Hospital, Medical College,
Shanghai Jiaotong University.
Image acquisition
All MRI examinations were performed on a 3T system
(Signa HD, General Electric Healthcare, Milwaukee, WI,
USA) equipped with an eight-channel cardiac array coil.
The scan range was from the umbilicus to the pubic
symphysis in the caudocranial direction. For any largerTable 1 The details of histopathological results in 56
solid adnexal lesions detected on 3T MRI
Histology diagnosis Numbers of lesions
Thecoma and fibrothecoma 18
Leiomyoma 14




Clear cell adenocarcinoma 1





Recurrent solid ovarian cancer 4
Total 56lesion that could not be fully accommodated on axial
imaging, a sagittal scanning sequence was performed to
include as much of the entire lesion as possible. Routine
MRI protocols were used for the assessment of the ad-
nexal masses, which included axial fast spin-echo (FSE)
T1-weighted images (T1WI), and sagittal FSE T2WI and
fat-suppressed T2WI (FS T2WI) in the axial plane. A
DWI-MRI sequence included an echo-planar imaging
sequence with an array spatial-sensitivity-encoding tech-
nique (ASSET). The parameter details of the T1WI MR
protocol were: repetition time (TR), 460 ms; echo time
(TE), 10 ms; number of excitations (NEX), 2; and thick-
ness, 6.0 mm. The parameter details of the T2WI MR
protocol were: TR, 2400 ms; TE, 85 ms; NEX, 1; and
thickness, 6.0 mm. The parameter details of the FS
T2WI MR protocol were: TR, 3160 ms; TE, 90 ms; NEX, 2;
and thickness, 6.0 mm. The parameter details of the DWI-
MRI protocol were: TR, 3500 ms; TE, 61 ms; NEX, 6; and
thickness, 6.0 mm; and the b value = 0 or 700 s/mm2. Liver
acquisition with a volume acceleration (LAVA) sequence
was used for contrast-enhanced pelvic imaging, and a
power injector (Missouri Ulrich; Ulm, Germany) was used
to inject the contrast material (Magnevist, Bayer Schering
Pharma AG, Germany). The parameter details of the
LAVA MR protocol were: TR, 3.4 ms; TE, 1.4 ms; NEX, 1;
flip angle, 15°; band width, 125 kHz. The images were ac-
quired in multiple phases of contrast medium enhance-
ment in both the sagittal and axial planes (precontrast
sagittal and axial oblique, and postcontrast at 20 s, 40 s,
60 s, and 80 s in the axial plane, and 120 s in the sagittal
plane). Details of the parameters of image acquisitions are
summarized in Table 2.
MRI image analysis
The MRI characteristics of each thecoma were recorded
separately, including the following items: 1) lesion com-
ponents (cystic, solid, cyst with septum, cyst with solid
components, cyst with septum and solid components);
2) signal intensity on T1WI/T2WI and DWI-MRI was
evaluated and recorded (hypo-, iso-, or hyperintensity on
T1WI; hypo-, iso-, or hyperintensity on T2WI; low, inter-
mediate, and high signal on DWI images). On T1WI,
hypo-, iso-, and hyperintensity were similar for the pelvic
fluid, pelvic wall muscle, and fat signal; on T2WI, hypo-,
iso-, and hyperintensity were similar for the pelvic bone,
pelvic wall muscle, and fat signal; on b = 700 mm–2/s
DWI images, the low, intermediate, high signal inten-
sities were similar for the pelvic bone, myometrium, and
endometrium. After the intravenous injection of the
contrast medium, the degree of lesion enhancement was
graded as follows: 1, minor enhancement (clearly less
than the myometrium); 2, mild enhancement (less than
the myometrium); 3, moderate enhancement (similar to
the myometrium); or 4, severe enhancement (more than
Table 2 Details of parameters for MRI imaging protocols
Parameters FSE-T1WI FSE-T2WI FS T2WI EPI-DWI LAVA
Repetition/echo time (msec) 460/10 2400/85 3160/90 3500/61 3.4/1.4
NEX 2 1 2 6 1
Thickness(mm) 6 6 6 6 4
Field of view (mm) 36 36 36 40 38
Matrix 320 × 224 256 × 224 256 × 224 96 × 130 320 × 224
Flip angle (degrees) 15
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15 and 7 years of experience in gynecological imaging,
respectively), who were blinded to the histological re-
sults, independently analyzed all the MRI datasets for
each participant on a PACS terminal server. Consensus
was achieved for any interobserver discrepancies in the
evaluation of the adnexal lesions or G.F.Z.’s decision was
arbitrarily accepted.
The ADCs were calculated by one observer (H.Z.) on
a commercially available postprocessing workstation (GE
Advantage Workstation 4.3, General Electric Healthcare,
Milwaukee, WI, USA). Regions of interest were drawn
manually in both the cystic and solid areas, with no
more than three sites in each lesion on b = 700 mm–2/s
DWI-MRI images. A circle or ellipsis with an area range
of 160–320 mm2 was placed centrally in the targeted re-
gion. Only the lowest ADC value was used for the subse-
quent statistical analysis.
Statistical analyses
Continuous variables were expressed as means ± stand-
ard deviation (SD) or as medians ± numerical ranges and
compared with an unpaired t test if normally distributed
(Mann–Whitney test if not normally distributed). SPSS
version 13.0 (SPSS Inc., Chicago, USA) was used to per-
form all statistical analyses. A p value of less than 0.05
indicated a statistically significant difference.
Results and discussion
The histological results revealed 18 ovarian thecomas in
18 patients (10 patients who underwent laparotomy andTable 3 Baseline characteristics and ADC values of 56 patient
Histology diagnosis Numbers Age(years)
Thecoma 18 59.9 ± 10.8*
59.5 (42–81)$
Leiomyoma 14 47.8 ± 16.5
51.0 (24–73)
Other solid ovarian mass 24 54.6 ± 14.8
58.0 (13–78)
Total 56 54.6 ± 14.6
56.5 (13–81)
*indicates mean ± standard deviation; $ indicates median and range (minimum – meight patients who underwent laparoscopic surgery).
Two patients were perimenopausal and all the other pa-
tients were postmenopausal. All the thecomas were uni-
lateral lesions, five of which were accompanied by other
ovarian etiologies, including uterine fibroids (n = 3),
endometrial polyps (n = 1), or fibroma and ligamentous
leiomyoma (n = 1). All the patients presented to the
gynecological department of our institution complaining
primarily of a pelvic or abdominal mass, with no previ-
ous gynecological disease history, except in one patient
with renal carcinoma (surgical resection five years earl-
ier) incidentally detected on a routine follow-up abdom-
inal MRI examination. There was no postmenopausal
bleeding or vaginal discharge in this patient cohort. The
baseline characteristics of the 18 thecomas are listed in
Table 3.
MRI characteristics
In this patient population, all the thecomas were round or
almost round solid masses with clear margins, except in
one patient, who had cystic and solid components (patho-
logically proven to be luteinized thecoma) (Figure 1). In
most cases, the lesion signals were homogeneously
isointense on T1WI (17/18, 94.4%) and on T2WI (11/18,
61.1%). An isointense signal mixed with a patchy high sig-
nal (n = 4) (Figure 2) or low signal (n = 2) was also com-
monly observed on T2WI. No obvious pelvic fluid was
seen in any patient. On the postcontrast images, nine le-
sions (50%) displayed minor enhancement, six mild en-
hancement, and three moderate enhancement. On b = 700
mm–2/s DWI images, 11 of the 18 lesions (11/18, 61.1%)s with pathologically proven solid adnexal masses
Maximum diameter(mm) ADC(10-3/mm2/s)
66.6 ± 46.0 1.20 ± 0.45
42.0 (23–80) 1.08 (0.70-2.20)
53.2 ± 21.0 1.48 ± 0.42
46.5 (27–106) 1.38 (0.90-2.50)
70.3 ± 42.1 1.26 ± 0.51
66.5 (19–192) 1.09 (0.50-2.20)
64.8 ± 39.3 1.30 ± 0.47
50.0 (19–192) 1.15 (0.50- 2.50)
aximum).
Figure 1 A 60-year-old female patient with luteinized thecoma. (a) Axial T1WI revealed a cystic solid mass with hypo–isointense signal in the
right adnexal region (arrow). (b) On sagittal T2WI, the cystic component of the tumor gave a homogeneous hyperintense signal. Note that
degenerated uterine fibroids (arrowhead) were also detected. (c) On fat-suppressed T2WI, the signal of the mass was similar to that in (b). (d) On
contrast-enhanced fat-suppressed T1WI, the solid components (arrow) of the lesion showed moderate enhancement, like that of the
myometrium. (e) On DWI-MRI (b = 700 s/mm2), the upper part of lesion appears as a homogeneous isointense signal and the lower part as a
hyperintense signal. (f) ADC map shows the marked hyperintense signal of the cystic components (T2 shine-through effect) and the isointense
signal of the solid components. The ADC values at the corresponding sites are 2.82 × 10–3 mm2/s (cyst) and 1.00 × 10–3 mm2/s (solid).
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tensity, two low signal intensity, and one mixed signal in-
tensity. The mean ADC value for the thecoma group was
1.20 ± 0.45 × 10–3 mm2/s. The details of the MRI charac-
teristics of the ovarian thecomas are listed in Table 4.Figure 2 A 57-year-old female patient with thecoma. (a) Axial T1WI rev
adnexal region (arrow). (b) On sagittal T2WI, the solid tumor, 116 mm in m
signal located eccentrically and an intermediate signal located peripherally
in (b). (d) On contrast-enhanced fat-suppressed T1WI, the lesion showed m
(b = 700 s/mm2), the lesion appeared as a homogeneous hyperintense sign
peripheral hypointense signal. The ADC value at the corresponding site is 1Comparison with other solid ovarian masses
In this study, 14 ligamentous leiomyomas (Figure 3) and
28 solid ovarian masses, including 20 primary ovarian
tumors (Figure 4) and four recurrent solid ovarian can-
cers, were included in the comparative group (Table 1).ealed a solid mass with a mostly iso–hypointense signal in the left
aximum diameter, showed a heterogeneous signal with patchy high
. (c) On fat-suppressed T2WI, the signal of the mass was similar to that
ild enhancement, less than that of the myometrium. (e) On DWI-MRI
al. (f) ADC map shows the hypointense signal with a marked
.75 × 10–3 mm2/s.






Components MR signal (T1WI/T2WI/
Enhancement)




1 76 180.00 Solid Iso/iso-hyperintensity/Mild Low 2.23
2 51 29.00 Solid Iso/isointensity/Minor High 0.82 Uterine fibroid
3 60 42.00 Cyst/solid Iso/isointensity/Moderate High 1.00 Fibroma,
leiomyoma
4 57 116.00 Solid Iso/iso-hyperintensity/Mild Low/High 1.75
5 57 89.00 Solid Iso/isointensity/Minor Intermediate 1.80
6 65 23.00 Solid Iso/isointensity/Minor Intermediate 1.09
7 81 64.00 Solid Iso-hypo/isointensity/Mild High 0.88 Endometrial polyps
8 50 32.00 Solid Iso/isointensity/Mild Intermediate 1.06
9 59 37.00 Solid Iso/iso-hypointensity/Minor Intermediate 1.33 Uterine fibroid
10 55 42.00 Solid Iso/isointensity/Minor Intermediate 0.94
11 43 135.00 Solid Iso/iso-hyperintensity/Mild Intermediate 1.10
12 48 77.00 Solid Iso/iso-hyperintensity/Moderate High 1.14 Uterine fibroid
13 64 126.00 Solid Iso/iso-hyperintensity/Mild Intermediate 1.55
14 71 77.00 Solid Iso/isointensity/Mild Intermediate 0.71
15 42 26.00 Solid Iso/isointensity/Minor Intermediate 0.68
16 69 34.00 Solid Iso/isointensity/Minor Intermediate 0.85
17 67 42.00 Solid Iso/isointensity/Minor Intermediate 0.97
18 64 25.00 Solid Iso/hypointensity/Moderate Low 1.47
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masses are summarized in Table 5. The mean age of the
thecoma group (59.9 ± 10.8 years) was clearly higher than
that of the leiomyoma group (47.8 ± 16.5 years; p = 0.018),
but similar to that of patients with other solid ovarian
masses (54.6 ± 14.8 years; p = 0.201; Table 6). There was
no significant difference in the maximum lesion diametersFigure 3 A 55-year-old female patient with broad ligament fibroid. A
region (arrow) was apparent on both T1WI (a) and T2WI (b). (c) On fat-supp
contrast-enhanced fat-suppressed T1WI, the lesion showed moderate enha
s/mm2), the lesion appeared as a homogeneous isointense signal. (f) The le
1.10 × 10–3 mm2/s at the corresponding site.of each group, although the maximum diameter in other
solid ovarian mass group was a little larger than the diam-
eters of the other groups. The mean ADC value of the
thecoma group (1.20 ± 0.45 × 10–3 mm2/s) was almost
equal to that of the group of other solid ovarian masses
(1.26 ± 0.51 × 10–3 mm2/s; Figure 5), but lower than the
mean ADC for leiomyomas (1.48 ± 0.42 × 10–3 mm2/s),round solid mass with mostly isointense signal in the left adnexal
ressed T2WI, the signal was similar to that in (a) and (b). (d) On
ncement, similar to that of the myometrium. (e) On DWI-MRI (b = 700
sion shows intermediate signal on ADC map, with the ADC value of
Figure 4 A 59-year-old female patient with serous cystadenocarcinoma. (a) Axial T1WI revealed a lobulated solid mass with isointensity in
the right adnexal region (arrow). (b) On sagittal T2WI, the solid tumor displayed homogeneous isointensity. (c) On contrast-enhanced fat-
suppressed T1WI, the lesion showed mild enhancement. (d) On DWI-MRI (b = 700 s/mm
2), the lesion appeared as hyperintensity. (e) ADC map
demonstrates homogeneous isointensity, with an ADC value of 1.00 × 10–3 mm2/s.
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solid masses were categorized into a benign group (includ-
ing 18 thecomas, two fibromas, and three Brenner tu-
mors) and a malignant group (19 lesions), there was no
significant difference in their maximum diameters (62.3 ±
42.2 and 76.4 ± 44.5, respectively) or ADC values (1.16 ±
0.47 × 10–3 and 1.33 ± 0.48 × 10–3 mm2/s, respectively),
but age differed significantly (60.7 ± 10.2 and 52.3 ± 15.4
years, respectively; p = 0.042; Table 6). The ADCs of the
benign group and leiomyoma group differed significantly
(p = 0.043), although a wide overlap between the two
groups was observed (Figure 6).
Ovarian thecoma is a solid ovarian tumor of gonadal
stromal-cell origin, although cystic degeneration and
varying degrees of edema can be observed in larger le-
sions [3-5]. Generally, ovarian thecoma is considered a
benign disease, although some anecdotal malignant cases
have been reported [2,3]. It is sometimes difficult to dif-
ferentiate these solid tumors from broad ligament
leiomyomas because their imaging features on ultra-
sound are similar [12]. Ascites and pleural effusionsTable 5 Baseline characteristics and ADC values (mean ± SD)
ovarian masses
Pathology group Numbers Age(years)
Benign 23 60.7 ± 10.2*
60.0 (42–81)$
Malignant 19 52.3 ± 15.4
52.0 (13–78)
Total 42 56.9 ± 13.3
59.0 (13–81)
*indicates mean ± standard deviation; $indicates median and range (minimum – maaccompanying the tumor (Meigs syndrome) may be
present in some cases [13], prompting an easy misdiag-
nosis of ovarian cancer. From this perspective, radiolo-
gists must be thoroughly familiar with the imaging
characteristics of these tumors to ensure their capacity
to make a correct preoperative diagnosis. When we
searched the literature, we found that studies focusing
on the MRI features of thecomas or fibrothecomas were
alarmingly limited, although MRI has been widely used
in the clinical context for any ovarian masses that are in-
determinate on computed tomography or US. In this
study, we analyzed 18 cases of histologically proven
thecoma and fibrothecoma with conventional MRI and
DWI. To our knowledge, no study of ovarian thecoma
in a large cohort sample with 3T MRI has previously
been published.
In this study, the mean age at onset of thecoma was 59.9
years and 16 patients (88.9%) were in the postmenopausal
period. Our results are consistent with the literature in that
thecoma predominantly affects postmenopausal women,
with a mean age of 59 years [2,3]. The peak incidenceof 42 patients with pathologically proven other solid
Maximum diameter(mm) ADC(10-3/mm2/s)
62.3 ± 42.2 1.16 ± 0.47
42.0 (19–180) 1.00 (0.50-2.20)
76.4 ± 44.5 1.33 ± 0.48
70.0 (20–192) 1.21 (0.70-2.20)
68.7 ± 43.3 1.24 ± 0.48
61.0 (19–192) 1.08 (0.50-2.20)
ximum).
Table 6 The statistically significant difference (p value) of
baseline characteristics and ADC values within three
groups in 56 patients with pathologically proven solid
adnexal masses
Pathology group Age Max
diameter
ADC(10-3/mm2/s)
Thecoma vs Leiomyoma 0.018 0.322 0.086
Leiomyoma vs Other solid mass 0.198 0.167 0.187
Thecoma vs Other solid mass 0.201 0.791 0.693
Benign vs Malignant 0.042 0.299 0.234
Leiomyoma vs Benign 0.006 0.459 0.043
Leiomyoma vs Malignant 0.424 0.081 0.378
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in the intraligamentous leiomyoma group (47.8 years;
p = 0.018). In this study, the lesions most often accom-
panying thecoma were uterine fibroids or intraligamentous
leiomyoma (4/18). In the 19 cases studied by Li XC et al.,
endometrial abnormalities (two cases with hyperplasia and
one case with endometrial carcinoma) accompanying the
thecoma were described as resulting from elevated levels
of estrogen [3]. In contrast to other studies [3,4,14], we ob-
served no ascites or pleural effusions in this study. The
mechanisms underlying these phenomena still require
clarification, but they may be related to the hormonal ac-
tivity of the thecoma.
According to the MRI findings in the present study, all
the thecomas were solid-component masses, regardless
of the lesion size, except for one cystic and solid mass,
with a pathological diagnosis of luteinized thecoma,Figure 5 Stem-and-leaf plots of the calculated ADC values (× 10–3 mm
thecoma group was almost equal to that of the other solid ovarian masses
significant difference between the groups.which is described in the literature as a rare condition
[15]. In another study of 19 patient samples, the authors
reported four lesions that presented as mostly cystic
masses on cross-sectional imaging [3], which could repre-
sent cystic degeneration or stromal edema. In these cases,
it is often impossible to distinguish these tumors from
ovarian epithelial tumors. Most of the thecomas examined
in our study appeared homogeneously isointense either on
T1WI (17/18, 94.4%) and T2WI (11/18, 61.1%) or on
DWI-MRI (11/18, 61.1%). However, we did find that the
larger lesions (four lesions > 100 mm in maximum diam-
eter) displayed a more heterogeneous signal on T2WI
(appearing as an iso–hyperintense signal) than did the
smaller tumors. Our observations are basically consistent
with those of the studies in the literature [3-5]. In a
study of 12 fibromas and fibrothecomas, Troiano et al.
reported that the patchy high signal on the T2WI im-
ages (representing cystic degeneration) occurred centrally
or eccentrically, whereas the low signal (representing
many fibro or thecal cellular components) was more often
peripheral [5]. We also noted this characteristic in the two
largest tumors (Figure 2). Because this feature is never
present in ovarian epithelial tumors, it may be an import-
ant MRI clue to the etiology of the mass if this is unclear
from well-documented morphological criteria. In terms
of lesion enhancement, Shinagare et al. studied the
MRI characteristics of 25 ovarian fibromas and 10
fibrothecomas, and demonstrated that the average
maximum percentage enhancement of the fibromas
and fibrothecomas was significantly lower than the en-
hancement of the myometrium and fibroids [4]. Of the2/s) for the three groups. The median ADC value (1.08) in the
(1.09), but less than that of the leiomyoma group (1.38). There was no
Figure 6 Stem-and-leaf plots of the calculated ADC values (10–3 ×mm2/s) of the three groups. The median ADC (1.00) in the benign solid
group was less than that in the malignant solid group (1.21) or the leiomyoma group (1.38). The difference between the benign solid group and
malignant solid group was not significant (p = 0.234), whereas the difference between the benign solid group and the leiomyoma group was
significant (p = 0.043).
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showed weak enhancement relative to that of the myo-
metrium. Thus, our results corroborate the view that
most thecomas show minor enhancement, which may
be useful in discriminating them from broad ligament
fibroids.
DW-MRI is a functional imaging technique that pro-
vides information about water mobility (Brownian move-
ment), tissue cellularity, and the integrity of cellular
membranes, and is gradually becoming part of the stand-
ard imaging protocols used to evaluate obstetric and
gynecological diseases [16]. The combination of conven-
tional MRI and DWI-MRI could improve lesion detection
and the better categorization of adnexal lesions [17], and
with the advantages of a contrast-free technique and a
shorter acquisition time (1–2 min), the use of the
DWI-MRI sequence can easily be added to routine im-
aging protocols. To the best of our knowledge, no
DWI-MRI evaluation of thecomas in relatively larger
numbers of patients and their comparison with ad-
nexal leiomyomas has been reported until now. In the
present study, most thecomas (11/18, 61.1%) displayed
intermediate signals (similar to that of the myome-
trium) on DWI-MRI, which may be attributable to the
presence of many fibroblasts and thecal cells [2]. Be-
cause thecomas are benign in nature, their DWI-MRI
characteristics may differ from those of malignant
ovarian tumors. In a study of 140 primary ovarian le-
sions, the authors reported that most of the malignant
tumors (27/42) produced a high signal on DWI-MRI[11]. In the present study, the mean ADC for the
thecoma group was lower than that of the leiomyoma
group or that of the other solid ovarian masses, al-
though none of these differences were significant. In
contrast to our study, Bakir et al. reported that the
mean ADC for fibrothecoma was higher than that for
ordinary leiomyoma [18]. The assessment of only two
fibrothecomas in that study may be responsible for this
discrepancy. The utility of ADC in the categorization
adnexal solid lesions has been reported in only a few
studies [11,18,19], so the conclusions still are conten-
tious because different b values were selected, varying
pathologies were examined, and the samples studied
had different volumes. In this study, the ADCs for the
solid ovarian masses in the benign group (23 lesions)
were slightly lower than those of the malignant group
(19 lesions), but not significantly so. The benign group,
which included thecomas, fibromas, and Brenner tu-
mors, all showed many closely arrayed spindle fibroids
and thecal cells, which would obviously reduce the
ADCs on DWI images. Our results are consistent with
those of other recently reported studies [11,18]. It is
noteworthy that there was a significant difference in
the ADCs for the benign solid ovarian tumors and
leiomyomas (p = 0.043). This result confirms that
ADCs can be used to differentiate benign ovarian solid
tumors from ligamentous leiomyomas.
There were some limitations to this study. First, there
was an inherent selection bias because the study was retro-
spective. However, all the patients underwent prospective
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The limited study sample size could also have influenced
the final results. Second, we compared our results using
3T MRI with other studies based on 1.5T MRI. The poten-
tial influence of this difference in magnetic field may have
made our comparison inaccurate. Third, the ADCs were
manually measured on the regions of interest based on in-
dividual habits. The lack of standardization in calculating
ADC may also have influenced the final results.
Conclusions
Ovarian thecoma or fibrothecoma often manifests as a
solid mass with homogeneous isointensity on both
T1WI/T2WI and DWI-MRI. There was no significant
difference in the ADCs for thecoma and other adnexal
solid masses, although the ADCs of the thecomas and
fibrothecomas were lower than those of the leiomyomas.
A significant difference in the ADCs for benign solid
ovarian masses and ligamentous leiomyomas was ob-
served, but this parameter was not useful in differentiat-
ing benign from malignant solid ovarian tumors.
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